
        <html>
        <head>
            <style>
                body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
                h3 { color: #333; }
                .question { margin-bottom: 15px; }
                .options { margin-left: 20px; margin-bottom: 10px; }
                .solution { background: #f8f9fa; padding: 10px; border-left: 4px solid #007bff; }
                .credits { text-align: center; margin-top: 20px; font-size: 18px; }
                .rainbow-text { 
                    background: linear-gradient(90deg, red, orange, yellow, green, blue, indigo, violet); 
                    -webkit-background-clip: text; 
                    color: transparent; 
                    font-weight: bold; 
                }
            </style>
        </head>
        <body>
        
            <div class="question">
                <h3>Question No: 1</h3>
                <p><b>Dysmenorrhea is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Painful menstruation</li><li>2. Increased frequency of menstruation</li><li>3. Increased menses during the reproductive period</li><li>4. The absence of menses during the reproductive period</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Dysmenorrhea means painful menstruation of sufficient magnitude so as to incapacitate day to day activities.</li><li>Mittelschmerz is synonymous to painful ovulation. Pain is associated with rupture of ovarian follicle at the time of ovulation. </li><li>A female giving history of sharp pain in lower abdomen, every month, 2 weeks before menstruation suggests Mittelschmerz as the diagnosis.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 2</h3>
                <p><b>Which of the following is a function of fallopian tube?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Implantation</li><li>2. Fertilization</li><li>3. Sperm production</li><li>4. Ovum production</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The fallopian tubes are bilateral conduits between the ovaries and the uterus in the female pelvis. They function as channels for oocyte transport and fertilization. Given this role, the fallopian tubes are a common etiology of infertility as well as the target of purposeful surgical sterilization. </li><li>The implantation normally takes place in the superior and posterior walls of the uterine body (corpus uteri) in the functional layer of the endometrium during the secretory phase of the cycle. Normal implantation zone of the blastocyst is in the superior and posterior wall of the uterine cavity. </li><li>Sperm production takes place inside the seminiferous tubules, which is a convoluted cluster of tubes located inside the testes. Testosterone production occurs in cells surrounding the seminiferous tubules, called Leydig cells.The ovaries produce the egg cells, called the ova or oocytes. The oocytes are then transported to the fallopian tube where fertilization by a sperm may occur. The fertilized egg then moves to the uterus, where the uterine lining has thickened in response to the normal hormones of the reproductive cycle.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 3</h3>
                <p><b>Normal pH of vagina is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 2 - 2.5</li><li>2. 3.5 - 4.5</li><li>3. 4.5 - 5.5</li><li>4. 5.0 - 6.5</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>pH of vagina: Normally, it is acidic due to doderlein’s bacilli, estrogen. Acidic pH prevents the uterus from infection (since age group is not mentioned, we will consider the adult in the reproductive age group). </li><li>Normal pH throughout reproductive life is 4 - 4.5.</li><li>pH during pregnancy: Less than 4 (becomes more acidic).</li><li>pH at birth: 5.5 - 6.0</li><li>pH during pre-pubertal age, menstruation and menopause is similar, i.e. 6.5 - 7.5.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 4</h3>
                <p><b>From which of the following layers does the regeneration of endometrium take place?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Zona basalis</li><li>2. Zona pellucidum</li><li>3. Zona compacta</li><li>4. Zona spongiosa</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Endometrium regenerates from zona basalis. </li><li>The basal layer adjacent to the myometrium remains intact and is the source of new endometrium.</li><li>This arises from the proliferation of the endometrial glandular remnants and the stroma of the interglandular connective tissue. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 5</h3>
                <p><b>All of the following are seen in fibroid; except:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Amenorrhea</li><li>2. Menstrual irregularity</li><li>3. Infertility</li><li>4. Pelvic mass</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormalCxSpFirst" style="margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:18.0pt;mso-add-space:auto;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Fibroids are abnormalgrowths that develop in or on a woman's uterus. Sometimes these tumors becomequite large and cause severe abdominal pain and heavy periods. <o:p></o:p></span></p><p class="MsoNormalCxSpMiddle" style="margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:18.0pt;mso-add-space:auto;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Fibroids do not lead toamenorrhea (is missing in one or more periods); they lead to menorrhagia (isheavy or prolonged menstrual bleeding) / metrorrhagia.<o:p></o:p></span></p><p class="MsoNormalCxSpMiddle" style="margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;mso-add-space:auto;text-indent:-18.0pt;line-height:115%;mso-list:l1 level1 lfo2"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings">§<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp; </span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Metrorrhagia— (Irregular bleeding) - Normally a fibroid does not lead to metrorrhagia butif it does then it is a case of fibroid polyp.<o:p></o:p></span></p><p class="MsoNormalCxSpMiddle" style="margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:36.0pt;mso-add-space:auto;text-indent:-18.0pt;line-height:115%;mso-list:l1 level1 lfo2"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings">§<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp; </span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Dysmenorrhea—congestiveas well as spasmodic type is seen.<o:p></o:p></span></p><p class="MsoNormalCxSpMiddle" style="margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:18.0pt;mso-add-space:auto;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Fibroid is responsiblefor &lt;3% cases of infertility.<o:p></o:p></span></p><p class="MsoNormalCxSpMiddle" style="margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:18.0pt;mso-add-space:auto;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Fibroids lead toabruption placenta. <o:p></o:p></span></p><p></p><p class="MsoNormalCxSpMiddle" style="margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:18.0pt;mso-add-space:auto;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Fibroids lead to PPH dueto increased surface area of uterus. &nbsp;&nbsp;<o:p></o:p></span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 6</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The outer layer of the vaginal wall is under the direct influence of:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Androgen</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Progesterone</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Aldosterone</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Estrogen</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Vaginal wall comprises of four layers:</strong><strong>&nbsp;</strong></p>
<p><strong><img title="1nn.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f8f6e0e7-1ba9-44fe-9ef9-5f908a3afcd7.png" alt="" width="500" height="477" /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong></p>
<p><strong>Figure: </strong>Vaginal Wall</p>
<ul>
<li>The outer layer is composed of pink squamous epithelium and connective tissue. It is under the direct <strong>influence of the hormone estrogen</strong> and contains many mucus-producing cells. This outer layer of epithelium lies in transverse folds called rugae. These transverse folds allow the vagina to expand during intercourse; they also facilitate vaginal delivery of a fetus.</li>
<li>The second layer is the submucosal layer. It contains the blood vessels, nerves and lymphatic channels.</li>
<li>The third layer is composed of smooth muscle and the fourth layer consists of connective tissue and the vascular network.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 7</h3>
                <p><b>Sequentially arrange the correct progression of fallopian tube anatomy from proximal (uterus) to distal (fimbriae): <p>Infundibulum<p> Isthmus<p> Ampulla</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 2→1→3</li><li>2. 2→3→1</li><li>3. 1→3→2</li><li>4. 3→1→2</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Fallopian tube is also called oviduct, this serpentine tube extends 7 to 10 cm from the uterine cornua. </li><li>Anatomically; subdivided into four parts: The uterine part (interstitial), the isthmus, the ampulla (the longest and widest part) and the infundibulum (the funnel-shaped termination formed of fimbriae, which opens into the abdominal cavity). </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 8</h3>
                <p><b>The length of fallopian tube is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 6 - 7 cm</li><li>2. 7 – 10 cm</li><li>3. 15 – 18 cm</li><li>4. 18 – 20 cm</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The length of fallopian tube is 4 inches or 7-10 cm.</li><li><b>Parts of fallopian tube are:</b></li><ul type ="circle"> <li><b>Interstitium (Intramural):</b> 1.25 cm long and 1 mm diameter (narrowest part). It has no longitudinal muscles; only circular muscles are present and acts as anatomical sphincter.  </li><li><b>Isthmus:</b> 2.5 cm long and 2 mm in diameter (second narrowest part); acts as physiologic sphincter.  </li><li><b>Ampulla:</b> Widest and longest part (5 cm) and fertilization occurs here. </li><li><b>Fimbria/infundibulum:</b> 1.25 cm long with a maximum diameter of 6 mm.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 9</h3>
                <p><b>Development of ovaries results from:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Genital ridge</li><li>2. Sinovaginal bulb of urogenital sinus</li><li>3. Testicular cords</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Ovaries develop from genital ridge. </li><li>Sinovaginal bulb of urogenital sinus results in the development of lower vagina. </li><li>Testicular cords represent the developing testis on USG. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 10</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the type of malformation in the given below image:</strong></p>
<p><strong><img title="Screenshot 2025-01-23 115333.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/3395e528-1fb2-4983-8b7e-14e5ed223b18.png" alt="" width="200" height="200" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Unicornuate uterus</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Uterus didelphys</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bicornuate uterus</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Septate uterus</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>&nbsp;</p>
<p class="MsoNormal" style="mso-add-space: auto; text-indent: -21.3pt; line-height: 115%; margin: 0cm 0cm 10.0pt 21.3pt;"><strong style="background-color: transparent; font-family: var(--mat-expansion-container-text-font); font-size: var(--mat-expansion-container-text-size); letter-spacing: var(--mat-expansion-container-text-tracking); color: var(--mat-expansion-container-text-color);"><span style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-font-kerning: 1.0pt; mso-ligatures: standardcontextual; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: TH;">Uterus Didelphys</span></strong><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">: <o:p></o:p></span></strong></p>
<p class="MsoListParagraphCxSpFirst" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Both mullerian ducts arepresent but not fused. So, two vaginas are seen. <o:p></o:p></span></p>
<p class="MsoListParagraphCxSpLast" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Only condition where two vaginasare present.&nbsp; <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 21.3pt; text-indent: -21.3pt; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Unicornuate uterus: <o:p></o:p></span></strong></p>
<p class="MsoListParagraphCxSpFirst" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l2 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Single mullerian ductpresent and single fallopian tube. <o:p></o:p></span></p>
<p class="MsoListParagraphCxSpLast" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l2 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">On USG, banana shapeduterus is seen.<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-add-space: auto; text-indent: -21.3pt; line-height: 115%; margin: 0cm 0cm 10.0pt 21.3pt;"><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Bicornuateuterus: <o:p></o:p></span></strong></p>
<p class="MsoListParagraphCxSpFirst" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l3 level1 lfo3;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Incomplete fusion of<strong> </strong>mullerianduct. <o:p></o:p></span></p>
<p class="MsoListParagraphCxSpLast" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l3 level1 lfo3;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Present with two uterinehorns and single vagina.&nbsp; <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left: 21.3pt; text-indent: -21.3pt; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Septate uterus:&nbsp;<o:p></o:p></span></strong></p>
<p class="MsoListParagraphCxSpFirst" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l1 level1 lfo4;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Fused mullerian duct andsepta is formed but septa don&rsquo;t resolve.<o:p></o:p></span></p>
<p>&nbsp;</p>
<p class="MsoListParagraphCxSpLast" style="margin-left: 21.3pt; mso-add-space: auto; text-indent: -21.3pt; mso-list: l1 level1 lfo4;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;">&middot;<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Two uterine horns andsingle vagina. &nbsp;<o:p></o:p></span></p>
<p>&nbsp;</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 11</h3>
                <p><b>After how many days of ovulation, embryo implantation occurs?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 3–5 days</li><li>2. 7–9 days</li><li>3. 10–12 days</li><li>4. 13–15 days</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Best answer would be implantation begins on day 6 and is completed by day 10 or 11. </li><li>According to the given options, the answer will be 7–9 days.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 12</h3>
                <p><b>Human placenta is best described as:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Discoidal</li><li>2. Hemochorial</li><li>3. Deciduate</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Human placenta is discoid-disc like in shape. </li><li>Hemochorial because of direct contact of chorion with maternal blood.</li><li>Deciduate i.e. it is shed at the time of parturition.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 13</h3>
                <p><b>Uteroplacental blood flow at term is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 300 – 500 mL/min</li><li>2. 500 – 700 mL/min</li><li>3. 700 – 900 mL/min</li><li>4. 900 – 1100 mL/min</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Using ultrasound to study the uterine arteries, utero placental blood flow has been measured to increase progressively during pregnancy from approximately 450 mL/min in mid trimester to nearly 500 – 750 mL/min at 36 weeks.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 14</h3>
                <p><b>Fetal side of the placenta is formed by:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Villi</li><li>2. Inner cell layer</li><li>3. Chorion frondosum</li><li>4. Ectoderm</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The chorion frondosum is the part of the chorion that develops into the fetal portion of the placenta, where the fetal blood vessels interact with the maternal blood supply to facilitate nutrient and gas exchange. </li><li>Villi are present on the fetal side but are part of the chorion frondosum. Villi themselves are not the structure that forms the fetal side.</li><li>Inner cell layer: The inner cell mass of the blastocyst gives rise to the embryo and not the fetal side of the placenta. </li><li>Ectoderm: The ectoderm is one of the three primary germ layers in the developing embryo and does not directly form the fetal side of the placenta.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 15</h3>
                <p><b>Functional unit of placenta is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Lobe</li><li>2. Cotyledon</li><li>3. Villi</li><li>4. Chorion frondosum</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Villous “trees” are the main structure of the placenta. Terminal villi are the functional unit of the placenta, which transfers electrolytes, O2, CO2 and nutrients between the mother and fetus.</li><li>Other options are distractors. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 16</h3>
                <p><b>Portion of the placenta contributed by the embryo is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Chorion</li><li>2. Yolk sac</li><li>3. Amnion</li><li>4. Allantois</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The chorion is the fetal part of the placenta which develops from the trophoblast and extraembryonic mesoderm. It plays an important role in the exchange of nutrients and gases between the mother and fetus.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 17</h3>
                <p><b>Which of the following is not a risk factor for CA cervix?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Human papilloma virus infection</li><li>2. Low parity</li><li>3. Multiple sexual partner</li><li>4. Smoking</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="line-height:115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif">Low parity (havingfewer children or being nulliparous) is not considered a risk factor forcervical cancer. In fact, high parity (having many children) has been morecommonly associated with an increased risk of cervical cancer.</span><b style="background-color: transparent; font-family: var(--mat-expansion-container-text-font); font-size: var(--mat-expansion-container-text-size); letter-spacing: var(--mat-expansion-container-text-tracking); color: var(--mat-expansion-container-text-color);"><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">&nbsp;</span></b></p><p class="MsoNormal" style="line-height:115%"><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN"><b>Factorspredisposing to CIN/Ca cervix:</b><o:p></o:p></span></p><p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l1 level1 lfo1"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:EN-IN">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Most common: HumanPapilloma Virus (HPV) infection-75%<o:p></o:p></span></p><p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l1 level1 lfo1"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:EN-IN">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Smoking<o:p></o:p></span></p><p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l1 level1 lfo1"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:EN-IN">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Sexuallytransmitted infections:<o:p></o:p></span></p><p class="MsoNormal" style="margin-left:54.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo2"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Courier New&quot;;mso-fareast-font-family:&quot;Courier New&quot;;mso-ansi-language:EN-IN">o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Poor socioeconomicstatus and poor personal hygienic <o:p></o:p></span></p><p class="MsoNormal" style="margin-left:54.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo2"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Courier New&quot;;mso-fareast-font-family:&quot;Courier New&quot;;mso-ansi-language:EN-IN">o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Coitus before 18years of age<o:p></o:p></span></p><p class="MsoNormal" style="margin-left:54.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo2"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Courier New&quot;;mso-fareast-font-family:&quot;Courier New&quot;;mso-ansi-language:EN-IN">o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Multiparity<o:p></o:p></span></p><p class="MsoNormal" style="margin-left:54.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l0 level1 lfo2"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Courier New&quot;;mso-fareast-font-family:&quot;Courier New&quot;;mso-ansi-language:EN-IN">o<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Multiple sexpartners<o:p></o:p></span></p><p class="MsoNormal" style="margin-left:18.0pt;text-indent:-18.0pt;line-height:115%;mso-list:l1 level1 lfo1"><!--[if !supportLists]--><span style="font-size:14.0pt;line-height:115%;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:EN-IN">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><!--[endif]--><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Immunocompromisedindividuals <o:p></o:p></span></p><p class="MsoNormal" style="margin-left:18.0pt;line-height:115%"><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:EN-IN">Women on OCP, Progesterone therapy for long time arepredisposed to adenocarcinoma of endocervix.</span><b><span style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;mso-font-kerning:0pt;mso-ligatures:none;mso-ansi-language:EN-IN;mso-bidi-language:AR-SA"> </span></b><b><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif"><o:p></o:p></span></b></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 18</h3>
                <p><b>Primary prevention of CA Cervix is done by:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. HPV vaccination</li><li>2. Drug therapy</li><li>3. Annual mammograms</li><li>4. Regular exercise</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>HPV vaccination is the most effective method for preventing cervical cancer. Vaccines such as Gardasil protect against the most common high-risk strains of HPV (including types 16 and 18), which are responsible for the majority of cervical cancer cases. </li><li>While barrier contraceptives and regular screening may help reduce risk, HPV vaccination has been shown to significantly lower the risk of developing cervical cancer. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 19</h3>
                <p><b>Which of the following is the most common symptom of cervical cancer?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Postcoital vaginal bleeding</li><li>2. Pelvic pain</li><li>3. Abnormal vaginal discharge</li><li>4. Pain during intercourse</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The most common symptom of cervical cancer is postcoital vaginal bleeding, particularly after intercourse or between periods. </li><li>Other symptoms such as pelvic pain, abnormal discharge, and pain during intercourse may also occur, but vaginal bleeding is typically the first sign in more advanced stages. </li><li>Early-stage cervical cancer is often asymptomatic, which is why regular screening is so important. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 20</h3>
                <p><b>First ‘cervical cancer vaccine’ of India is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Cervavac</li><li>2. Gardasil</li><li>3. Gardasil 9</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>First ‘cervical cancer vaccine’ of India is Cervavac. Prepared in Serum Institute of India, Pune. </li><li>Gardasil is a Quadrivalent vaccine which provides protection against genital warts and cervical cancer. </li><li>Gardasil 9 is a non-valent vaccine effective against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, providing protection against genital warts.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 21</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the instrument shown below:</strong></p>
<p><strong><img title="Screenshot 2025-01-23 115522.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/cb0f06b7-0228-4d99-b76d-84695b71554e.png" alt="" width="200" height="33" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ayre&rsquo;s spatula</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Colposcope</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Wire loop</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>None of the above</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The given instrument is Ayre&rsquo;s spatula.</li>
<li>Wooden Ayre&rsquo;s spatula is used to take specimen for screening of carcinoma cervix. The long end is inserted into cervical canal and is rotated in 360 degree.</li>
<li>The other broad end is used for obtaining cells from lateral vagina.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 22</h3>
                <p><b>Which of the following is a well-established risk factor for ovarian cancer?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Early menopause</li><li>2. Use of oral contraceptives</li><li>3. History of pelvic inflammatory disease (PID)</li><li>4. Nulliparity</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Nulliparity (never having children) is a well-established risk factor for ovarian cancer. </li><li>Having children, particularly at a younger age, is thought to provide a protective effect, possibly due to a reduction in ovulation and hormonal changes. </li><li>Other factors, such as oral contraceptive use, are protective rather than risk-enhancing.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 23</h3>
                <p><b>Most common type of ovarian tumor is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Germ cell tumor</li><li>2. Epithelial ovarian tumor</li><li>3. Sex cord stromal tumor</li><li>4. Metastatic tumor</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Most common type of ovarian cancer is Epithelial ovarian tumor (90%) in which serous tumor is most common type. </li><li>In germ cell tumor teratoma is most common. </li><li>Sex cord stromal tumor may be estrogen secreting, i.e. Granulosa cell tumor, stromal tumor (Fibroma, Thecoma, etc.)</li><li>Krukenberg tumor is metastatic tumor.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 24</h3>
                <p><b>Pap smear is usually done to determine cancer of:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Cervix</li><li>2. Ovaries</li><li>3. Fallopian tubes</li><li>4. Breast</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Papanicolaou (Pap) smear is done to detect cervical cancer. </li><li>It can’t detect cancer in ovaries and fallopian tubes because these organs remain outside of the uterus and the abnormal cells from these organs will not be detected from a smear done on the cervix. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 25</h3>
                <p><b>Which of the following tumor is benign?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Choriocarcinoma</li><li>2. Squamous cell carcinoma</li><li>3. Leiomyoma</li><li>4. Immature teratoma</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p><b>Table:</b> Tumors and tissues of origin</p><table class="TableGrid1" border="1" cellspacing="0" cellpadding="0" style="border-collapse: collapse;border:none;mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook: 1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"> <tbody><tr>  <td width="240" valign="top" style="width:179.95pt;border:solid windowtext 1.0pt;  mso-border-alt:solid windowtext .5pt;background:yellow;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><b><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;  mso-fareast-font-family:Calibri;color:red">Tissue of origin<o:p></o:p></span></b></p>  </td>  <td width="239" valign="top" style="width:179.25pt;border:solid windowtext 1.0pt;  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:  solid windowtext .5pt;background:yellow;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><b><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;  mso-fareast-font-family:Calibri;color:red">Benign<o:p></o:p></span></b></p>  </td>  <td width="240" valign="top" style="width:180.3pt;border:solid windowtext 1.0pt;  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:  solid windowtext .5pt;background:yellow;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><b><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:&quot;Times New Roman&quot;,serif;  mso-fareast-font-family:Calibri;color:red">Malignant<o:p></o:p></span></b></p>  </td> </tr> <tr>  <td width="240" valign="top" style="width:179.95pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Squamous cells<o:p></o:p></span></p>  </td>  <td width="239" valign="top" style="width:179.25pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Papilloma<o:p></o:p></span></p>  </td>  <td width="240" valign="top" style="width:180.3pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Squamous cell  carcinoma<o:p></o:p></span></p>  </td> </tr> <tr>  <td width="240" valign="top" style="width:179.95pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Neuroectoderm<o:p></o:p></span></p>  </td>  <td width="239" valign="top" style="width:179.25pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Naevus<o:p></o:p></span></p>  </td>  <td width="240" valign="top" style="width:180.3pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Malignant melanoma<o:p></o:p></span></p>  </td> </tr> <tr>  <td width="240" valign="top" style="width:179.95pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Smooth muscle<o:p></o:p></span></p>  </td>  <td width="239" valign="top" style="width:179.25pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Leiomyoma<o:p></o:p></span></p>  </td>  <td width="240" valign="top" style="width:180.3pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Leiomyosarcoma<o:p></o:p></span></p>  </td> </tr> <tr>  <td width="240" valign="top" style="width:179.95pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Germ cells<o:p></o:p></span></p>  </td>  <td width="239" valign="top" style="width:179.25pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Mature teratoma<o:p></o:p></span></p>  </td>  <td width="240" valign="top" style="width:180.3pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Immature teratoma<o:p></o:p></span></p>  </td> </tr> <tr>  <td width="240" valign="top" style="width:179.95pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Glands or ducts<o:p></o:p></span></p>  </td>  <td width="239" valign="top" style="width:179.25pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Adenoma<o:p></o:p></span></p>  </td>  <td width="240" valign="top" style="width:180.3pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Adenocarcinoma<o:p></o:p></span></p>  </td> </tr> <tr>  <td width="240" valign="top" style="width:179.95pt;border:solid windowtext 1.0pt;  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;  padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Placenta tissue<o:p></o:p></span></p>  </td>  <td width="239" valign="top" style="width:179.25pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Hydatidiform mole<o:p></o:p></span></p>  </td>  <td width="240" valign="top" style="width:180.3pt;border-top:none;border-left:  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt">  <p class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:  115%"><span lang="EN-US" style="font-size:14.0pt;line-height:115%;font-family:  &quot;Times New Roman&quot;,serif;mso-fareast-font-family:Calibri">Choriocarcinoma<o:p></o:p></span></p>  </td> </tr></tbody></table><p><br></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 26</h3>
                <p><b>Which of the following is a typical symptom of endometrial hyperplasia?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Excessive bleeding</li><li>2. Chronic pelvic pain</li><li>3. Fever and chills</li><li>4. Abdominal bloating</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Endometrial hyperplasia commonly presents with excessive or abnormal uterine bleeding due to the thickened endometrial lining. </li><li>This bleeding can be heavy or unpredictable, often manifesting as menorrhagia or metrorrhagia. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 27</h3>
                <p><b>The total amount of water retained during pregnancy:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 4 liters</li><li>2. 6 liters</li><li>3. 9 liters</li><li>4. 10 liters</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The total amount of water retained in pregnancy is 6.5 liters. </li><li>Because so much of water is retained in pregnancy that is why edema is normal during pregnancy.</li><li>Total weight gained in pregnancy is 11 – 12 kg.</li><li>Net weight gained, that is the extra weight which is left after delivery, is 5 – 6 kg.</li><li>BMI increases in pregnancy by 10 percent.</li><li>Other options are distractors. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 28</h3>
                <p><b>Which of the following would be most appropriate for a nurse to use when describing menarche to a 13-year-old?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. A female’s first menstruation or menstrual “period”</li><li>2. The first year of menstruation or “period”</li><li>3. The entire menstrual cycle or from one “period” to another</li><li>4. The onset of uterine maturation or peak growth</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Menarche refers to the onset of the first menstruation or menstrual period and refers only to the first cycle. </li><li>Uterine growth and broadening of the pelvic girdle occurs before menarche.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 29</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the procedure in the given image:</strong></p>
<p><strong><img title="Screenshot 2025-01-23 115621.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/055ecde1-bdc1-49d8-b943-ffd2198f259f.png" alt="" width="250" height="300" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fundal grip (1st Leopold)</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lateral grip (2nd Leopold)</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pawlik grip (3rd Leopold)</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pelvic grip (4th Leopold)</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The given image depicts Pawlik grip, which is a part of Leopold maneuver.</li>
<li><strong>Fundal grip</strong> is when you palpate a patient while you can see their face. The head is indicated by a smooth, hard, and spherical mass, whereas the breech is suggested by a broad, soft, and irregular mass. Both fetal poles are inaccessible in the fundal area during a transverse lay.</li>
<li>The location of the back, limbs, and anterior shoulder can be determined using a lateral grip.</li>
</ul>
<p><img src="data:image/jpeg;base64,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" /></p>
<ul>
<li><strong>Pawlik grip:</strong> When fingers and thumb are approximately positioned, the presenting section is clearly grasped and the movement from side to side is examined. The transverse lie leaves Pawlik&rsquo;s hold bare.</li>
<li><strong>Pelvic grip:</strong> The patient is examined while facing the patient&rsquo;s feet. It is carried out to identify the component residing in the uterus lower pole. If it is a head, important traits include: a) a definite presentation area; b) attitude; and c) interaction.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 30</h3>
                <p><b>In pregnancy, which is considered as severe hypertension?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 130/80 mmHg</li><li>2. 140/90 mmHg</li><li>3. 150/100 mmHg</li><li>4. 160/110 mmHg</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The most common cause of severe hypertension in pregnancy is pre-eclampsia, which presents after 20 weeks of gestation. Severe hypertension in pregnancy is defined as a sustained systolic blood pressure of 160 mmHg or over or diastolic blood pressure of 110 mmHg or over. Hence, option d. is correct. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 31</h3>
                <p><b>The nurse observes a shiny surface after delivery of baby from vagina, what is the name of this method of placenta separation and refers to which surface?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Schultz method, baby</li><li>2. Schultz method, mother</li><li>3. Duncan method, baby</li><li>4. Duncan method, mother</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>The maternal side of the placenta is usually dark red in color, while the fetal side is shiny and almost translucent in color. In the Schultz method, separation begins in the center of the placenta (the fetal surface), and this part descends first, with the remainder following. <b>Hence, option a. is correct.</b></li><li>The Matthew Duncan separation method involves detachment of the leading edge of the placenta, and the entire organ slips down and out of the uterus sideways. In this, the leading edge of placenta and maternal surface presents first. </li></ul><p><img src="data:image/jpeg;base64,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"><b></b></p><p><b>Figure:</b> The diagram is showing the placental separation methods. Fig.(a) depicts Schultz method and Fig.(b) depicts Duncan method.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 32</h3>
                <p><b>In addition to changing the mother’s position to relieve cord pressure, the nurse may employ the following measures in the event that she observes the cord out of the vagina:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Immediately, pour sterile saline on the cord and repeat every 15 minutes to prevent drying</li><li>2. Cover the cord with a wet sponge</li><li>3. Apply a cord clamp to the exposed cord and cover with a sterile towel</li><li>4. Keep the cord warm and moist by continuous applications of warm sterile saline compresses</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>The immediate priority is to minimize pressure on the cord. Thus, the nurse’s initial action involves placing the client on bed rest and then placing the client in a knee-chest position or lowering the head of the bed and elevating the maternal hips on a pillow to minimize the pressure on the cord (Trendelenburg Position). </li><li>Option a: Saline should be warmed; waiting 15 minutes may not keep the cord moist. </li><li>Option b: This choice does not specify what the sponge was wet with, information is inadequate. </li><li>Option c: This measure would stop circulation to the fetus. </li><li>Option d: The cord should be kept warm and moist to maintain fetal circulation. This measure is an accepted nursing action.</li></ul><p><img src="data:image/jpeg;base64,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"><font face="Arial" size="3"></font></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 33</h3>
                <p><b>After performing a sterile vaginal exam on a client who has just been admitted to the unit in active labor and placed on an electronic fetal monitor, the RN assesses that the fetal head is at +2 station. She documents this on the monitor strip. Fetal head at +2 station means that the fetal head is located in the pelvis at:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. One centimeter below the ischial spine</li><li>2. One centimeter above the ischial spine</li><li>3. The pelvic outlet</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>Fetal station in obstetrics refers to the position of the presenting part of the baby in relation to the ischial spine of the mother&rsquo;s pelvis.</li><li>A station of +2 means that the baby&rsquo;s head is descended two centimeter below the ischial spine but has not yet entered the birth canal (vaginal canal). This indicates that the baby&rsquo;s head is engaged in the pelvis and is descending further down in preparation for delivery.</li></ul><p><img src="data:image/jpeg;base64,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"></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 34</h3>
                <p><b>A nurse is conducting a vaginal examination on a pregnant client in labor. The nurse assesses that the fetal head is at a station of -1. What does this station value indicate regarding the fetal’s head position in the pelvis?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. The fetal head is at the level of the ischial spine</li><li>2. The fetal head is one centimeter below the ischial spine</li><li>3. The fetal head has not yet entered the pelvic inlet</li><li>4. The fetal head is located in the pelvic outlet</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>In obstetrics, the station refers to the position of the fetal head in relation to the ischial spines of the pelvis. The ischial spines are considered 0 station.<ul ><li>A station of -1 means that the fetal head is 1 centimeter above the ischial spines and has not yet entered the pelvic inlet.</li><li>As the fetal head descends, the station becomes more positive, with +1, +2, +3 indicating descent toward the pelvic outlet. </li></ul> <p>Thus, a station of -1 indicates that the fetal head is still above the ischial spines, which means it has not yet entered the pelvic inlet.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 35</h3>
                <p><b>A patient of 41-week gestation is in labour unit with 3 cm cervix dilation, duration of contraction is 70 sec. Patient is on Oxytocin infusion. The nursing priority for this patient is to:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Check FHR</li><li>2. Stop Oxytocin</li><li>3. Change Position</li><li>4. Increase dose of Oxytocin</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The standard of care for an induction according to the Association of Women’s Health, Obstetric and Neonatal Nurses and American College of Obstetrics and Gynecology is that contractions should not exceed 60 seconds in an induction. Inductions should simulate normal labor; 70-secondS contractions during the latent phase (3 cm) are not the norm. The next contractions can be longer and increase risks to the mother and fetus. </li><li>Contractions lasting 60-90 seconds during transition are typical; this provides a good distractor. The nurse needs to be knowledgeable of the phases and stages of labor. </li><li>So, the step should be to stop the oxytocin infusion. After that, FHT should be monitored continuously with an induction of labor; this is an accepted standard of care. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 36</h3>
                <p><b>During the first postpartum day, uterus is just lateral to the umbilicus indicating:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Constipation</li><li>2. Bladder distension</li><li>3. Sub involution</li><li>4. Retained part</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>On the first postpartum day, the uterus is typically expected to be at or just below the level of the umbilicus. If the uterus is lateral to the umbilicus, it can suggest that there is a full bladder, which may push the uterus to the side. This is a common cause of uterine displacement and can interfere with proper uterine contraction and involution. <ul ><li>Urine retention or bladder distention commonly displaces the uterus to the right and may delay involution. </li><li>Bowel distention and constipation are common in the postpartum period but do not displace the uterus laterally. </li><li>Sub involution is a condition in which the uterus does not return to its normal size.</li><li>Retained part causes bleeding. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 37</h3>
                <p><b>A postpartum patient complains of rectal pressure, severe pain in perineum, nurse anticipate probability of:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Constipation</li><li>2. Vulvar hematoma</li><li>3. Cystitis</li><li>4. Afterbirth pain</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Afterbirth pain is a common complaint in the postpartum client, but they are located in the uterus. </li><li>Constipation may cause rectal pressure but is not usually associated with severe pain. </li><li>Cystitis may cause pain, but the location is different. </li><li>Hematomas are frequently associated with severe pain and pressure. Further, assessments are indicated for this client. </li><li>When a postpartum patient complains of rectal pressure and severe pain in the perineum and if the symptoms are associated with swelling and discoloration of the vulva, a vulvar hematoma is a likely the probability. A vulvar hematoma is a collection of blood in the soft tissues of the vulva, usually occurring due to trauma or a tear during childbirth. The blood accumulates in the tissue causing pressure, pain and swelling. </li><li>It is crucial for the nurse to recognize the signs and symptoms of a vulvar hematoma promptly. Timely assessment and intervention, often involving surgical drainage, are necessary to prevent complications and relieve the patient’s pain and discomfort. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 38</h3>
                <p><b>A pregnant client comes to the office for her first prenatal examination at 10 weeks. She has been pregnant twice; the first delivery produced a viable baby girl at 39 weeks 3 years ago; the second pregnancy produced a viable baby boy at 36 weeks 2 years ago. Both children are living well. Using the GTPAL system to record her obstetrical history, the nurse should record:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 3-2-0-0-2</li><li>2. 2-2-0-2-2</li><li>3. 3-1-1-0-2</li><li>4. 2-1-1-0-2</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>This answer is an incorrect application of the GTPAL method.</li><li>One prior pregnancy was a parity birth at 36 weeks (T = 1, P = 1; not T = 2). (B) This answer is an incorrect application of the GTPAL method. The client is currently pregnant for the third time (G = 3, not 2), one prior pregnancy was parity (T = 1, P = 1; not T = 2), and she has had no prior abortions (A = 0). (C) This answer is the correct application of GTPAL method. The client is currently pregnant for the third time (G = 3), her first pregnancy ended at term (>37 weeks) (T = 1), her second pregnancy ended preterm 2033 weeks) (P = 1), she has no history of abortion (A = 0), and she has two living children (L = 2). (D) This answer is an incorrect application of the GTPAL method. The client is currently pregnant for the third time (G = 3, not 2).</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 39</h3>
                <p><b>A 35-weeks-pregnant client is undergoing a non-stress test (NST). During the 20-minute examination, the nurse notes three fetal movements accompanied by accelerations of the fetal heart rate, each 15 bpm, lasting 15 seconds. The nurse interprets this test to be:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Nonreactive</li><li>2. Reactive</li><li>3. Positive</li><li>4. Negative</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>In a nonreactive NST, the criteria for reactivity are not met. (B) A reactive NST shows at least two accelerations of FHR with fetal movements, each 15 bpm, lasting 15 seconds or more, over 20 minutes. (C, D) This term is used to interpret a contraction stress test (CST), or oxytocin challenge test, not an NST.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 40</h3>
                <p><b>A pregnant client continues to visit the clinic regularly during her pregnancy. During one of her visits while lying supine on the examining table, she tells the RN that she is becoming light-headed. The RN notices that the client has pallor in her face and is perspiring profusely. The first intervention the RN should initiate is to:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Place the examining table in the Trendelenburg position</li><li>2. Assess the client to see if she is having vaginal bleeding</li><li>3. Obtain the client’s vital signs immediately</li><li>4. Help the client to be in a sitting position</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>This position would cause the gravid uterus to bear the increased pressure of the vena cava, which could lead to maternal hypotension, in turn causing the client to continue to have pallor and to feel light-headed. (B) This would not be the first intervention the RN should initiate. The RN should understand the supine position and its effect on the gravid uterus and vena cava. (C) The RNs first intervention should be one that helps to alleviate the client’s symptoms. Obtaining her vital signs will not alleviate her symptoms. (D) This would move the gravid uterus off; of the client’s vena cava, which would alleviate the maternal hypotension that is the cause of her symptoms.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 41</h3>
                <p><b>A pregnant woman at 28 weeks of gestation visited ante-natal clinic at a primary health centre for the first time. Her hemoglobin level was found to be 9 gm. The management will include:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Tablet iron folic acid - one tablet (containing 60 mg elemental iron and 500 microgram of Folic acid) daily</li><li>2. Tablet iron folic acid - one tablet (containing 50 mg elemental iron and 500 microgram of Folic acid) weekly</li><li>3. Blood Transfusion</li><li>4. Tablet iron folic acid - two tablet (containing 60 mg elemental iron and 500 microgram of Folic acid) daily</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>WHO Guidelines<ul ><li>Mild anemia Hb - 10-10.9: management- Diet, Iron folic acid tablet OD</li><li>Moderate anemia- 7-10: Diet, Oral iron folic acid BD</li><li>Severe anemia- less than 7 gm: Blood transfusion preferable.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 42</h3>
                <p><b>Whether the woman had ovulation or not on day 21 of the menstrual cycle will be best determined by:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Serum Inhibin B</li><li>2. Serum FSH</li><li>3. Progesterone</li><li>4. Serum LH</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p><img src="data:image/png;base64,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"></p><ul><li>Minimum levels of LH and FSH are seen in luteal phase (as high concentration of progesterone → has -ve feedback on LH and FSH).</li><li>Progesterone attains its highest peak about 8 days after the LH peak like day when corpus luteum has maximum function.</li><li>Progesterone levels are the best indicator of whether ovulation has occurred in the menstrual cycle. After ovulation, the corpus luteum (which forms from the ruptured follicle) secretes progesterone to prepare the endometrium for a potential pregnancy. If ovulation has occurred, progesterone levels rise significantly around day 21 of the menstrual cycle (which is typically in the luteal phase).</li><li>Here’s an explanation of the other options:</li><li>Option a. Serum Inhibin B: Inhibin B levels are higher during the follicular phase and drop after ovulation, but it is not as direct an indicator of whether ovulation has occurred as progesterone.</li><li>Option b. Serum FSH: Follicle-stimulating hormone (FSH) is involved in the development of ovarian follicles and rises at the beginning of the menstrual cycle. However, its levels are not a direct indicator of ovulation.</li><li>Option d. Serum LH: Luteinizing hormone (LH) surges just before ovulation (typically around day 14 of a 28-day cycle), but after ovulation, its levels drop. While the LH surge indicates imminent ovulation, progesterone is a more reliable marker for confirming ovulation, especially by day 21. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 43</h3>
                <p><b>If conjugate of the diagonal is ‘a’ cm, obstetric conjugate will be:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. a + 1 cm</li><li>2. a + 2 cm</li><li>3. a – 1 cm</li><li>4. a – 2 cm</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Obstetric conjugate normally measures 10 cm or more.</li><li>The pelvic inlet is considered to be contracted, if obstetric conjugate is less than 10 cm. </li><li>It cannot be measured clinically but can be estimated by subtracting 1.5 cm from the diagonal conjugate. Since in question, 1.5 cm is not given, we are taking as ‘a – 2 cm’. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 44</h3>
                <p><b>If both the ala of the sacrum bone is absent, pelvis is called as:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Naegele’s pelvis</li><li>2. Robert pelvis</li><li>3. Triradiate pelvis</li><li>4. Rachitic pelvis</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>If one ala is absent–pelvis is called as Naegele’s pelvis.</li><li>If both ala of sacrum are absent-pelvis is called as Robert’s pelvis.</li><li>Both are varieties of contracted pelvis and in each cesarean delivery is done.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 45</h3>
                <p><b>A primigravida was admitted to the labor room at 40 weeks of gestation for the induction of labor. The obstetrician has planned to induce with misoprostol (PGE1). What dose to be used?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 25 mg</li><li>2. 25 mcg</li><li>3. 50 mg</li><li>4. 50 mcg</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>PGE1- Misoprostol dose is 25 mcg vaginally 6 hourly or 25 mcg orally 2 hourly for induction of labor. </li><li>It can be used either transvaginally or orally.</li><li><b>Side effects:</b></li><ul type ="circle"> <li>Uterine tachysystole </li><li>Meconium stained amniotic fluid </li><li>Uterine rupture </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 46</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A nurse is admitting a post-date client at 43 weeks of gestation to the labor and delivery unit for induction of labor. What is a predictor of a successful induction?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A Bishop score of 10</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A firm and posterior cervix</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A history of precipitous labor</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>A reactive non-stress test</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><img title="1nn.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/44498ba5-a778-41d0-b306-86534d0e95f5.png" alt="" width="600" height="350" /></p>
<ul>
<li>The Bishop score is a system for rating the inducibility of the cervix. The cervix is scored (0, 1, 2, or 3) on consistency, position, dilation, effacement, and station of the fetal presenting part. Usually, a score 28 indicates that labor induction will be successful (i.e., result in vaginal birth).</li>
<li><strong>Option-b:</strong> A cervix that is firm and posterior is associated with a low Bishop score, which reflects a low likelihood of successful labor induction.</li>
<li><strong>Option-c:</strong> A history of a precipitous labor may increase future risks of precipitous labor, once the labor is established. However, in this case, labor has not begun and is to be induced.</li>
<li><strong>Option-d:</strong> A reactive non-stress test indicates that the fetus is well oxygenated, but it does not provide information about the likely success or failure of labor induction.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 47</h3>
                <p><b>A 26-year-old term primigravida presents to the gynae clinic for a regular checkup. On examination, uterus corresponds to term, and head of the fetus is non-engaged. What is the most common cause for this finding?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Cephalopelvic disproportion</li><li>2. Deflexed head</li><li>3. Brow presentation</li><li>4. Breech</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The most common cause of non-engagement at term in a primigravida is deflexed head > Cephalopelvic disproportion. </li><li>The most common cause of un-engaged head was deflexed head in 28% women, cephalopelvic disproportion (CPD) in 13.34%, loop of the cord around the neck in 6%, placenta previa type in 5.33% whereas no cause could be identified in 40%. </li><li>No-engagement at the onset of active phase of labor is predictor of the risk of caesarean section.</li><li>The problems of prolonged labor are that the woman is exposed to high risk of infection, ketosis and obstructed labor while the fetus faces the danger of asphyxia and infection.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 48</h3>
                <p><b>The most common cause of true Cephalopelvic Disproportion (CPD) in India is:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Malpresentation</li><li>2. Rickets</li><li>3. Trauma</li><li>4. Occipito posterior position</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The most common cause of true Cephalopelvic Disproportion (CPD) in India is rickets.</li><li>CPD can be either true CPD or relative CPD. </li><li>The most common cause of true CPD in developing countries is vitamin d deficiency and rickets; and the most common cause of true CPD in developed countries is trauma to the pelvis. </li><li>Relative CPD is the most common type. It is caused due to malposition (Occipito posterior position/brow position).</li></ul></div></div>
            <div class="question">
                <h3>Question No: 49</h3>
                <p><b>Dysfunctional uterine bleeding is caused by:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Fibroids</li><li>2. Endometriosis</li><li>3. Imbalance in the hypothalamo-pituitary-ovarian axis</li><li>4. Ovarian cyst</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li> DUB is mainly anovulatory. </li><li> DUB is defined as regular heavy menstrual bleeding without any postcoital or intermenstrual bleeding or any palpable pelvic pathology and should have a normal cervical smear result. </li><li> It is mainly due to an imbalance in the hypothalamo-pituitary-ovarian axis.</li><li> Bleeding occurs due to the hypertrophy and hyperplasia of the endometrium induced by a high titer of estrogen in the circulating blood.</li><li> This is the reason why, initially due to lack of progesterone - patients complain of amenorrhea and later on, due to excessive estrogen they complain of excessive bleeding.</li></ul></div></div>
            <div class="question">
                <h3>Question No: 50</h3>
                <p><b>Upper part of vagina is derived from:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Mullerian duct</li><li>2. Sinovaginal bulb of urogenital sinus</li><li>3. Wolffian duct</li><li>4. Both a and b</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li> Upper vagina develops from mullerian duct and lower from sinovaginal bulb of urogenital sinus.</li><li> Upper and lower vagina fuses to form transverse septa which resolves by 20 weeks of pregnancy. If not, results in transverse vaginal septum. </li><li> Wolffian duct results in development of male internal genital organs.</li></ul></div></div>
        <div class="credits">
            <p class="rainbow-text">Credit: Code Written by BHASKAR</p>
        </div>
        </body></html>